FOXA1 and acute respiratory distress syndrome: Based on the results of core signaling analyses and considering relative protein/gene expression levels of non-viral ARDS as compared with normal nasopharyngeal tissues [58], we additionally selected TF FOXA1 as an essential biomarker (drug target) of specific etiologic mechanisms for non-viral ARDS.